Nizatidine (Preferred Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Nizatidine drug offered from Preferred Pharmaceuticals Inc.. This Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Preferred Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | Nizatidine |
SUBSTANCE NAME: | NIZATIDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2015-08-28 |
END MARKETING DATE: | 0000-00-00 |
Nizatidine HUMAN PRESCRIPTION DRUG Details:
Item Description | Nizatidine from Preferred Pharmaceuticals Inc. |
LABELER NAME: | Preferred Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 150(mg/1) |
START MARKETING DATE: | 2015-08-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 68788-8913_d2d06182-2653-47ea-b96a-08f5700a8970 |
PRODUCT NDC: | 68788-8913 |
APPLICATION NUMBER: | ANDA090618 |
Other NIZATIDINE Pharmaceutical Manufacturers / Labelers: